• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Imaging and Intervention

Radiofrequency tags may safely localize nonpalpable breast lesions

byXiaofan PanandDylan Wolman
May 27, 2015
in Imaging and Intervention, Obstetrics, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. This study’s finding indicate that radiofrequency identification tags may be a safe and effective method of preoperative, wireless localization of nonpalpable breast lesions, without localization failures or postoperative infection.

2. Breast resections occurring with radiofrequency guidance were confirmed by successful detection of the identification tags in excised specimens.

Evidence Rating Level: 2 (Good)

Study Rundown: Breast cancer is the second most commonly diagnosed cancer, affecting 1 in 8 women in the United States. A common procedure in the treatment of nonpalpable breast tumors is surgical excision, typically preceded by insertion of a wire and hook into the lesion to direct tumor removal. Wire localization may be complicated by procedural pain and inconsistent accuracy, warranting research into alternative techniques. Radiofrequency identification is an emerging tool which may allow for precise tissue location using implanted radiofrequency tags to mark the excisional site, avoiding the standard wire which may either migrate or cause pain following insertion. The current study was a small pilot evaluation of such radiofrequency identification tags as a localization method for nonpalpable breast lesions. The primary focus was on the safety of the technique as defined by tag migration and postoperative infection within 30 days, while also examining localization capability through successful removal of the lesion itself without intralesional loss of the tag. Radiofrequency identification was found to reliably locate the lesions without tag migration from the placement site, as confirmed by excisional specimens, with no reported postoperative infections. As a small pilot study, limitations were primarily related to the small sample size. Future studies should examine the generalizability of these findings within a larger cohort while additionally determining the duration of safe tag implantation and comparing if radiofrequency tags may reduce excisional volumes relative to wire localizers.

Click to read the study in the American Journal of Roentgenology

Relevant Reading: Radiofrequency identification tags for preoperative tumor localization: proof of concept.

RELATED REPORTS

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

2 Minute Medicine Rewind August 10, 2026

In-Depth [prospective cohort]: Twenty consecutive women of mean age of 53 years all with lesions less than 6 cm in depth from the skin of the breast underwent hook-wire placement and radiofrequency identification tagging immediately prior to surgery. The tag itself is a passive microchip encased within a glass capsule, measuring 2 x 12 mm in size, which is then localized with a handheld wire-loop detection device which reads the unique identification number stored on the microchip. Both hook-wire and radiofrequency identification tag localization was performed in women requiring preoperative localization prior to surgery. The radiofrequency identification tags were used to localize individual breast lesions for surgical excision while the hook wire device was delegated as backup in case of identification tag migration or localization error. Radiofrequency identification tag function within the lesion of interest was assessed with a loop probe against the overlying skin following percutaneous placement of the identification tag. In all 20 subjects, breast lesions were then surgically removed as guided by the radiofrequency identification tag with no postoperative infections occurring within 30 days. No localization failures occurred and each uniquely identifiable tag was confirmed within the excised specimen with hand-held detector. Tag migration was reported in 3 subjects as the lesion was being retracted as a part of the procedure, with no episodes of tag migration reported prior to incision.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast Cancerradiofrequency identification
Previous Post

Antibiotic stewardship program for asymptomatic bacteriuria may be effective

Next Post

Traffic noise exposure may be a risk factor for central obesity

RelatedReports

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Chronic Disease

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

August 13, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Chronic Disease

A digital mental health intervention may improve anxiety in breast cancer survivors

July 31, 2026
Next Post
Colonic byproduct may decrease long-term weight gain

Traffic noise exposure may be a risk factor for central obesity

New gene linked to male infertility

New gene linked to male infertility

Financial incentive programs significantly improve smoking cessation

Financial incentive programs significantly improve smoking cessation

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bundibugyo Ebola outbreak surpasses 5,700 cases without a validated vaccine
  • Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy
  • Looksmaxxing raises body dysmorphia concerns among adolescent males
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in